Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Banco de datos
Tipo de estudio
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
World Dev ; 121: 163-177, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-31481824

RESUMEN

Over the last few decades rapid advances in processes to collect, monitor, disclose, and disseminate information have contributed towards the development of entirely new modes of sustainability governance for global commodity supply chains. However, there has been very little critical appraisal of the contribution made by different transparency initiatives to sustainability and the ways in which they can (and cannot) influence new governance arrangements. Here we seek to strengthen the theoretical underpinning of research and action on supply chain transparency by addressing four questions: (1) What is meant by supply chain transparency? (2) What is the relevance of supply chain transparency to supply chain sustainability governance? (3) What is the current status of supply chain transparency, and what are the strengths and weaknesses of existing initiatives? and (4) What propositions can be advanced for how transparency can have a positive transformative effect on the governance interventions that seek to strengthen sustainability outcomes? We use examples from agricultural supply chains and the zero-deforestation agenda as a focus of our analysis but draw insights that are relevant to the transparency and sustainability of supply chains in general. We propose a typology to distinguish among types of supply chain information that are needed to support improvements in sustainability governance, and illustrate a number of major shortfalls and systematic biases in existing information systems. We also propose a set of ten propositions that, taken together, serve to expose some of the potential pitfalls and undesirable outcomes that may result from (inevitably) limited or poorly designed transparency systems, whilst offering guidance on some of the ways in which greater transparency can make a more effective, lasting and positive contribution to sustainability.

2.
Psychol Rep ; 64(1): 159-62, 1989 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-2928425

RESUMEN

Some of the contradictions in psychological research may be attributable to failure to distinguish statistical from clinical significance. 82 articles in which the MMPI was the research instrument were analyzed to see how often the results reported as significant were in fact large enough to warrant such a conclusion. Articles were classified as to whether or not the clinical interpretations were consistent with the statistical results. Excluding articles in which data were insufficient to reach an independent conclusion, 54.90% of the articles presented conclusions of clinical significance that were not supported by the data, while 45.10% reported clinical results that were supported by the data.


Asunto(s)
MMPI , Trastornos Mentales/psicología , Humanos , Psicometría , Investigación
4.
Environ Sci Technol ; 35(24): 4731-8, 2001 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-11775146

RESUMEN

Excess phytoplankton production, which contributes to hypoxic conditions, is nitrogen limited in the Chesapeake Bay during the summer months. Therefore, understanding the flux of ammonia by direct deposition to the biologically active surface layer is critical to understanding the nutrient dynamics of the bay. This paper presents the results of a 2-yr study measuring gaseous ammonia (NH3) and aerosol ammonium (NH4+) in Baltimore and Solomons, MD, from which direct atmospheric loading of total ammonia (Nt = NH3 + NH4+) to the Chesapeake Bay is estimated. Mean atmospheric concentrations of total ammonia for Baltimore and Solomons were 2.7 +/- 1.7 and 1.0 +/- 0.8 microg of N m(-3), respectively. Monte Carlo estimates of gross dry deposition ranged from <100 to 4900 microg of N m(-2) d(-1). However, based upon water quality parameters, Monte Carlo estimates of gross volatilization of NH3 were calculated to range from <100 to 7700 microg of N m(-2) d(-1). The resulting net air-sea exchange flux varied seasonally from a net deposition into the water during the winter to a net volatilizing into the atmosphere during the summer. A total of 60% of the paired air-water samples had flux estimates that were not significantly different than equilibrium at the 90% confidence interval. The gross deposition, gross volatilization, and net air-sea fluxes were greater and more variable in Baltimore relative to the rural site. Atmospheric ammonia concentrations decrease during the winter at the rural site. However, the net exchange is still into the water due to an exponential decrease in [NH3]eq with temperature. These results indicate that the nitrogen-limited Chesapeake Bay can act as a source of ammonia to the local atmosphere.


Asunto(s)
Amoníaco/análisis , Agua Dulce/análisis , Compuestos de Amonio Cuaternario/análisis , Contaminantes Químicos del Agua/análisis , Contaminantes Atmosféricos/análisis , Monitoreo del Ambiente/métodos , Gases/análisis , Fitoplancton/crecimiento & desarrollo , Literatura de Revisión como Asunto , Estaciones del Año , Estados Unidos , Volatilización , Movimientos del Agua
5.
Am J Hosp Pharm ; 38(11): 1693-5, 1981 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-7304621

RESUMEN

Routes through which health-care workers may be exposed to injectable antineoplastic drug products are reviewed, and recommendations developed by the National Institutes of Health for the safe handling of such products are presented. Routes of exposure are primarily through inhalation of the aerosolized drug product and by direct skin contact. The potential risks from repeated contact with injectable antineoplastic drug products can be controlled by the use of specific containment equipment and certain work techniques. It is recommended that all procedure involved in the preparation of injectable antineoplastics be performed in a Class II laminar flow biological safety cabinet.


Asunto(s)
Antineoplásicos/efectos adversos , Enfermedades Profesionales/prevención & control , Antineoplásicos/administración & dosificación , Composición de Medicamentos , Humanos , Inyecciones , Servicio de Farmacia en Hospital
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA